Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Amniotic Membrane Market Size, Share & Trends Analysis & Outlook to 2025, with an Expected CAGR of 12.6% - ResearchAndMarkets.com

March 13, 2019

DUBLIN--(BUSINESS WIRE)--Mar 13, 2019--The “Amniotic Membrane Market Size, Share & Trends Analysis Report By End Use (ASC, Hospital), By Enzyme (Dehydrated, Cryopreserved), By Application (Ophthalmology, Surgical Wounds), And Segment Forecasts, 2018 - 2025” report has been added to ResearchAndMarkets.com’s offering.

The global amniotic membrane market size is expected to reach USD 5.81 billion by 2025. The market is estimated to witness a CAGR of 12.6% during the forecast period.

Rise in trauma, burn cases and resulting surgeries along with increasing awareness regarding the benefits of these products are boosting the market growth. Rising number of cosmetic surgeries performed is also anticipated to drive the market during the forecast period.

Amniotic membrane is also used in the treatment of a large number of ocular surface diseases as it protects surfaces from microbial colonization preventing the risk of infections.

Moreover, presence of growth factors including basic Fibroblast Growth Factor (bFGF), Transforming Growth Factors (TGFs), Epidermal Growth Factor (EGF), Vascular Endothelial Growth Factor (VEGF), Nerve Growth Factor (NGF), and Keratinocyte Growth Factor (KGF) in amniotic membranes promote wound healing, accelerating its adoption globally. Thus, its benefits, such as anti-inflammatory properties, reduced fibrosis and scarring at the site of surgery, pain reduction, and wound healing properties, are also fuelling the demand.

These products are thus most commonly used in surgeries, treatment of venous, pressure, and diabetic foot ulcers, ophthalmology, and in the management of chronic wounds.

The American Association of Tissue Banks is a non-profit organization that regulates tissue donation in U.S. Presence of such tissue banks ensures zero disease transmission, which, in turn, propels market growth. Furthermore, a number of institutes are trying to introduce novel areas of applications for these products by focusing on the research activities in stem cell and regenerative medicines. This factor is also likely to support market expansion.

The use of cryopreserved amniotic membrane is largely seen in hospitals, Ambulatory Surgical Centers (ASCs), and specialty clinics. Lyophylization of the tissue post donation preserves the histological and biological activity of the tissue facilitating faster wound recovery.

Further key findings from the study suggest:

  • Cryopreserved is expected to be the dominant segment in future as it’s highly effective and ensures preservation of histological and biological properties
  • Surgical wounds segment is projected to witness high growth due to increasing usage of these products for surgical applications
  • Specialty clinics are anticipated to register the highest CAGR during the forecast period due to increasing number of cosmetic and reconstructive surgeries being performed
  • North America is a leading regional market owing to presence of a large number of key companies and high incidence of chronic and infectious diseases
  • The Asia Pacific region is expected to record the highest CAGR during the forecast period due to growing population and rising incidence of chronic diseases and burn injuries
  • Major companies in the amniotic membrane market include Alliqua BioMedical Inc.; Amnio Technology, Applied Biologics LLC; Human Regenerative Technologies DermaSciences; Katena Products, MiMedx Group Inc.; and Skye Biologics, Inc

Topics Covered

Chapter 1 Executive Summary

Chapter 2 Research Methodology

2.1 Country-wise Market: Base Estimates

2.2 Global Market: CAGR Calculation

2.3 Region-based Segment Share Calculation

2.4 Research Scope & Assumptions

2.5 List of Data Sources

2.5.1 Data for primary interviews, by sources

2.5.2 Data for primary interviews, by region

2.6 Market Snapshot

Chapter 3 Amniotic Membrane Market Variables, Trends & Scope

3.1 Market Segmentation & Scope

3.2 Market Driver Analysis

3.2.1 Rising research on stem cell biology and regenerative medicine

3.2.2 Increasing awareness towards benefits offered by amniotic membrane

3.2.3 Rise in the number of accident and trauma cases

3.3 Market Restraint Analysis

3.3.1 Lack of skilled professionals

3.3.2 Lack of standardized guidelines

3.4 Key Opportunities Prioritized

3.4.1 Key opportunities prioritized, by product

3.4.2 Key opportunities prioritized, by application

3.4.3 Key opportunities prioritized, by end use

3.5 Amniotic Membrane Market - SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

3.6 Industry Analysis - Porter’s

3.7 Amniotic Membrane Market: Company Market Position Analysis, 2017

Chapter 4 Amniotic Membrane Market: Enzyme Estimates & Trend Analysis

4.1 Amniotic Membrane Market: Product Movement Analysis

4.2 Cryopreserved Amniotic Membrane

4.3 Dehydrated Amniotic Membrane

Chapter 5 Amniotic Membrane Market: Application Estimates & Trend Analysis

5.1 Amniotic Membrane Market: Application Movement Analysis

5.2 Surgical Wounds

5.3 Ophthalmology

5.4 Others

Chapter 6 Amniotic Membrane Market: End Use Estimates & Trend Analysis

6.1 Amniotic Membrane Market: End Use Movement Analysis

6.2 Hospitals

6.3 Ambulatory Surgical Clinics

6.4 Specialty Clinics

6.5 Research and Academic Institutes

Chapter 7 Amniotic Membrane Market: Regional Estimates & Trend Analysis, by Product, Application, and End Use

7.1 Amniotic Membrane Market Share, by Region, 2017 & 2025

7.2 North America

7.3 Europe

7.4 Asia Pacific

7.5 Latin America

7.6 Middle East & Africa (MEA)

Chapter 8 Competitive Landscape

8.1 Company Profiles

8.1.1 Alliqua BioMedical Inc.

8.1.2 Amnio Technology LLC

8.1.3 Applied Biologics LLC

8.1.4 Human Regenerative Technologies LLC

8.1.5 DermaSciences

8.1.6 Katena Products Inc.

8.1.7 MiMedx Group Inc.

8.1.8 Skye Biologics Inc.

8.1.9 Amniox Medical Inc.

8.1.10 Integra LifeSciences

For more information about this report visit https://www.researchandmarkets.com/research/j7fhvt/global_amniotic?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190313005537/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Enzymes,Biomaterials



SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 03/13/2019 11:25 AM/DISC: 03/13/2019 11:25 AM


All contents © copyright 2019 The Associated Press.All rights reserved.